SARS Spike
- Known as:
- SARS Spike
- Catalog number:
- ANT-179
- Product Quantity:
- 100µg
- Category:
- -
- Supplier:
- Prospecbio
- Gene target:
- SARS Spike
Related genes to: SARS Spike
- Gene:
- SARS NIH gene
- Name:
- seryl-tRNA synthetase
- Previous symbol:
- -
- Synonyms:
- SERS
- Chromosome:
- 1p13.3
- Locus Type:
- gene with protein product
- Date approved:
- 1995-06-09
- Date modifiied:
- 2014-11-18
- Gene:
- SARS2 NIH gene
- Name:
- seryl-tRNA synthetase 2, mitochondrial
- Previous symbol:
- SARSM
- Synonyms:
- FLJ20450, mtSerRS, SerRSmt, SARS, SERS, SYS
- Chromosome:
- 19q13.2
- Locus Type:
- gene with protein product
- Date approved:
- 2002-10-09
- Date modifiied:
- 2016-11-09
Related products to: SARS Spike
62 kDa RNA-binding protein,Oryctolagus cuniculus,Rabbit,SARS,Serine--tRNA ligase,SerRS,SERS,Seryl-tRNA synthetase, cytoplasmic,Seryl-tRNA(Ser_Sec) synthetaseSARS coronavirus N Protein monoclonal antibody, clone 38j4SARS coronavirus N Protein monoclonal antibody, clone 8k5hA' SARS-CoV, Spike Antibody (OAMA02852)A' SARS-CoV, Spike Antibody (OAMA02863)A'SARS-CoV, M protein (NT) antibodyA'SARS-CoV, M protein (NT) antibody Polyclonal Antibodies Primary antibodiesA'SARS-CoV, M protein (NT) antibody Polyclonal Antibody Host: RabbitACE2 (SARS Receptor) Antibody (C-term)ACE2 (SARS Receptor) Antibody (C-term)ACE2 (SARS Receptor) Antibody (C-term) Blocking PeptideACE2 (SARS Receptor) Antibody (C-term) Blocking PeptideACE2 (SARS Receptor) Antibody (C-term) Purified Rabbit Polyclonal Antibody (Pab) Applications WB, IHC, EACE2 (SARS Receptor) Antibody (C-term) Purified Rabbit Polyclonal Antibody (Pab) Applications WB, IHC, EACE2 (SARS Receptor) Antibody (Center) Related articles to: SARS Spike
- Epidemiological data on herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections remain limited in the Middle East and North Africa. This study estimated HSV-1 and HSV-2 seroprevalence in the urban population of Qatar and examined associations with demographic characteristics. - Source: PubMed
Publication date: 2026/09/24
Nasrallah Gheyath KIssa FarahNizamuddin Parveen BTrad FarahQotba Hamda AZein NouranYounes NadinIsmail AhmedAyoub Houssein HYassine Hadi MChemaitelly HiamAbu-Raddad Laith J - The COVID-19 pandemic has posed unprecedented global public health challenges since its emergence in late 2019. Vaccination remains the most effective intervention for preventing severe disease and reducing transmission. However, disparities in vaccine distribution and access have been widely reported, particularly in low-income and middle-income countries and rural communities. Rural populations in sub-Saharan Africa (SSA) often face structural barriers, including weak health systems, limited infrastructure and an inadequate healthcare workforce, which may affect the availability and accessibility of COVID-19 vaccines. As COVID-19 vaccination transitions from emergency campaign delivery to integration within routine national immunisation programmes, coverage across the WHO African Region remains substantially below global targets and the residual unvaccinated population is disproportionately rural. Despite growing literature on COVID-19 vaccination, there remains limited synthesised evidence examining vaccine availability and accessibility among rural populations in SSA. This systematic review and meta-analysis aims to synthesise existing evidence regarding the availability and accessibility of SARS-CoV-2 vaccines among rural populations in SSA. - Source: PubMed
Publication date: 2026/09/24
Nyangi EliaBukagu YoktaniPaul MpangaMassawe NorberthMkumbwa RebeccaMwasanga ElinesiRuwaichi ThadeusMawi NeemaAbihudi SiriLuoga Pankras - Approximately 10% of individuals who recover from COVID-19 experience residual respiratory symptoms impacting their quality of life, but the mechanisms behind pulmonary long COVID (PLC) are largely unknown. - Source: PubMed
Publication date: 2026/09/24
Guinto ElizabethKuo I-ChihChopra SameekshaShin Samuel BGerayeli Firoozeh VYoo Jung-WanPark Hye-YunMessing MelinaLi XuanYang Chen XiGilchrist CassandraYehia DinaEddy Rachel LMilne StephenStach Tara RCheung Chung YYang Julia S WYip WilliamShaipanich TawimasLeipsic JonathonMcNagny Kelly MLeung Janice MSin Don D - - Source: PubMed
Publication date: 2026/09/24
Rao XiyunFan HuaDing ShiyiZhang ChiXin ZiyiZhao XuezhiJarvis Shivon BelleZhang XingweiWang MingweiZhao Lijun - Herein, we report a non-fluorescent 2,1,3-benzothiadiazole (BTD) derivative, BTD-PhCOOH, as a protein-triggered fluorogenic platform for SARS-CoV-2 spike protein detection. Direct coupling under mild refrigerated conditions afforded the BTD-Spike conjugate, producing an intense green fluorescence signal and demonstrating efficient fluorescence turn-on after protein ligation. Solvent-accessible surface area analysis (SASA) identified Lys529 as the most accessible lysine residue, providing a structural rationale for conjugate formation. In MCF-7 cells, BTD-Spike enabled time-dependent visualization of spike-associated cellular interactions, with membrane-associated fluorescence after 30 min and a more defined peripheral and intracellular punctate pattern after 60 min. In mice, systemic intravenous administration established the current sensitivity limits of visible-range whole-body and ex vivo organ fluorescence imaging, as treated animals could not be clearly distinguished from controls under these acquisition conditions. Importantly, higher-resolution confocal analysis of fixed brain tissue revealed localized fluorescence differences between treated and control samples. Additionally, direct intracerebroventricular administration enabled brain-level detection of both BTD-Spike and BTD-labeled amyloid-β, generating qualitatively distinct fluorescence patterns in the central nervous system. Overall, BTD-PhCOOH establishes a protein-activated fluorescence platform strongly supported by chemical, photophysical, computational, and cellular validation, while the brain-detection experiments highlight its potential for probing protein-associated signals in complex biological environments. - Source: PubMed
Publication date: 2026/09/22
Neto Brenno A DMota Alberto A RMota-Araujo Hannah PColodeti Lilian CRamos Isalira PerobaSantos-Rodrigues Erick FOliveira-Santos KetleyCorrea Jose RWalter-Nuno Ana BeatrizReis Luana LScalabrini-Machado Daniel FVieira Lúcio RFigueiredo Claudia P